All posts on January, 2016


Serious adverse drug reactions rare from certain treatment for vascular tumor in infants

Sorilla Prey, M.D., of the Université de Bordeaux, France and colleagues examined the safety of propranolol therapy in treating infantile hemangioma, a vascular tumor characterized by rapid growth during the first weeks of life. Severe forms require systemic therapy. Propranolol, a beta blocker, induces regression, but safety data have been lacking for children. The study appears in the Jan. 26 issue of JAMA.

Read more 0 Comments

Improved chances of discovering hereditary transthyretin amyloidosis

New insights in hereditary transthyretin amyloidosis (ATTR) improve the chances of diagnosing the genetic disease using ECG and ultrasound. In a new doctoral dissertation by Sandra Arvidsson at Umeå University in Sweden, an explanation to the varying symptoms in patients with ATTR is explored. Of particular interest is why the disease only affects the heart in some patients – pinpointing age and gender as important explanations.

Read more 0 Comments